Literature DB >> 30536331

Prognostic value of the response to prednisone for children with acute lymphoblastic leukemia: a meta-analysis.

J Gao1, W-J Liu.   

Abstract

OBJECTIVE: To systematically review prednisone induced test results in the prognosis assessment of acute lymphoblastic leukemia in children.
MATERIALS AND METHODS: Based on the established inclusion and exclusion criteria, studies of prednisone induced test in evaluating the prognosis of childhood acute lymphoblastic leukemia were electronically searched from January 1990 to November 2016 using Pubmed, Embase, The Cochrane Library, Web of Science, WanFang, VIP, and CNKI database. Two independent researchers browsed literature, extracted data and assessed the risk of bias of studies. Meta-analysis was performed using RevMen 5.3 software. A total of 17 articles were included.
RESULTS: Meta-analysis showed that after complete prednisone induced test in children, 5y-EFS, 8y-EFS adverse reactions, persistent remission and relapse were statistically significant differences between the prednisone good response (PGR) and prednisone poor response (PPR). There were statistical significance in T cell immune typing and the initial WBC of the two groups. Prognosis of prednisone good response group is better than prednisone poor response group.
CONCLUSIONS: The prednisone induction test is an important factor in predicting the prognosis of children with ALL.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30536331     DOI: 10.26355/eurrev_201811_16411

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

1.  Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.

Authors:  Lauren K Meyer; Benjamin J Huang; Cristina Delgado-Martin; Ritu P Roy; Aaron Hechmer; Anica M Wandler; Tiffaney L Vincent; Paolo Fortina; Adam B Olshen; Brent L Wood; Terzah M Horton; Kevin M Shannon; David T Teachey; Michelle L Hermiston
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

2.  Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.

Authors:  Anica M Wandler; Benjamin J Huang; Jeffrey W Craig; Kathryn Hayes; Hannah Yan; Lauren K Meyer; Alessandro Scacchetti; Gabriela Monsalve; Monique Dail; Qing Li; Jasmine C Wong; Olga Weinberg; Robert P Hasserjian; Scott C Kogan; Philip Jonsson; Keith Yamamoto; Deepak Sampath; Joy Nakitandwe; James R Downing; Jinghui Zhang; Jon C Aster; Barry S Taylor; Kevin Shannon
Journal:  Leukemia       Date:  2020-02-17       Impact factor: 11.528

3.  Hirsutanol A inhibits T-acute lymphocytic leukemia Jurkat cell viability through cell cycle arrest and p53-dependent induction of apoptosis.

Authors:  Fangfang Zhong; You Yang; Danwei Ren; Sili Long; Xiang Qin; Jing Liu; Yan Zeng; Wenjian Lan; Wenzhe Ma; Wenjun Liu
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

4.  Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of ex vivo treated pediatric T-cell acute lymphoblastic leukemia cells.

Authors:  Daniela Kuzilková; Cristina Bugarin; Katerina Rejlova; Axel R Schulz; Henrik E Mei; Maddalena Paganin; Alessandra Biffi; Andrea Biondi; Tomas Kalina; Giuseppe Gaipa
Journal:  Haematologica       Date:  2022-06-01       Impact factor: 11.047

5.  Association Between NR3C1 Mutations and Glucocorticoid Resistance in Children With Acute Lymphoblastic Leukemia.

Authors:  Haiyan Liu; Ziping Li; Fei Qiu; Chunjie Li; Xiaojing Lin; Yingyi He; Maoxiang Qian; Yuanbin Song; Hui Zhang
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

Review 6.  The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities.

Authors:  Lauren K Meyer; Michelle L Hermiston
Journal:  Cancer Drug Resist       Date:  2019-06-19

Review 7.  Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia-The State-of-the-Art Knowledge and Future Prospects.

Authors:  Kamil Kośmider; Katarzyna Karska; Agata Kozakiewicz; Monika Lejman; Joanna Zawitkowska
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

8.  The long-term outcome and risk factors for precursor B cell acute lymphoblastic leukemia without specific fusion genes in Chinese children: experiences from multiple centers.

Authors:  Pinli Zou; Min Zhou; Jinquan Wen; Xin Liao; Yali Shen; Haiyan Liu; Lin Song; Jianwen Xiao
Journal:  Bosn J Basic Med Sci       Date:  2022-04-01       Impact factor: 3.363

9.  [Prognostic significance and risk factors of minimal residual disease ≥1% on 19th day of induction chemotherapy in children with acute lymphoblastic leukemia].

Authors:  Jieming Yu; Tiantian Yi; Guanchuan Lin; Jianyun Wen; Libai Chen; Jiaqi Chen; Xuedong Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-02-29

10.  Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression.

Authors:  Cara E Toscan; Duohui Jing; Chelsea Mayoh; Richard B Lock
Journal:  Br J Cancer       Date:  2020-04-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.